Results 191 to 200 of about 680,508 (273)

Exploring Vocabularies of Motive to Optimise Patient Engagement for Drug Development

open access: yesSociology of Health &Illness, Volume 48, Issue 8, November 2026.
ABSTRACT Patient engagement in the drug development life cycle is becoming normalised, and the return on investment is being quantified. We sought to understand what motivates biotechnology organisations to undertake patient engagement throughout the drug development life cycle, to enable us to generate theoretically and empirically grounded knowledge ...
Julia Frost   +4 more
wiley   +1 more source

Predicting for Malignancy in Congenital Lung Malformations: A Single‐Center Study of the “At Risk” Pediatric and Adult Population

open access: yesThoracic Cancer, Volume 17, Issue 21, November 2026.
This single‐center outcome study of prospectively identified pediatric congenital lung malformations and concurrent retrospective incidence in adult mucinous carcinoma found that in children with CLMs no resected malignant lesions could be identified on medium‐term follow‐up.
Medha Sridhar Rao   +8 more
wiley   +1 more source

Treprostinil: Mechanism of Action, Clinical, and Translational Science

open access: yesClinical and Translational Science, Volume 19, Issue 11, November 2026.
ABSTRACT Treprostinil is a synthetic prostacyclin analogue with a tricyclic benzindene structure that confers markedly enhanced metabolic stability relative to native prostacyclin, enabling delivery by four distinct routes—intravenous, subcutaneous, inhaled, and oral—that together constitute a mainstay of pharmacotherapy for pulmonary arterial ...
Muhammad Sameed   +2 more
wiley   +1 more source

Successful Treatment with Surgical Resection for Nocardia cyriacigeorgica Infection in Pulmonary Sequestration. [PDF]

open access: yesIntern Med
Tsukaguchi A   +7 more
europepmc   +1 more source

Impact of YAQ001 on the Gut Microbiome, Permeability and Markers of Systemic Inflammation in Patients With Cirrhosis

open access: yesLiver International, Volume 46, Issue 11, November 2026.
ABSTRACT Background & Aims YAQ001 is a novel, non‐absorbable, gut‐restricted, multiporous, carbon bead adsorbent. Pre‐clinical studies and a clinical trial suggested its therapeutic potential and safety in patients with cirrhosis. This substudy aimed to explore the effects of YAQ001 on the gut microbiome and their exploratory association with ...
Jinxia Liu   +54 more
wiley   +1 more source

A comparison of normobaric and hypobaric hypoxia effects on cerebrovascular response pre and post maximal exercise

open access: yesExperimental Physiology, Volume 111, Issue 11, Page 5154-5165, 1 November 2026.
Abstract A lack of consensus remains on whether normobaric hypoxia (NH) and hypobaric hypoxia (HH) may differentially impact physiological factors affecting cerebrovascular regulation, particularly with an additional strenuous exercise component. We sought to compare the acute effects of NH and HH on global cerebral blood flow (gCBF) at an altitude ...
Rachel Turner   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy